Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review

Detalhes bibliográficos
Autor(a) principal: Ferreira, Wagner Andrade
Data de Publicação: 2023
Outros Autores: Neves, Vivian dos Santos, Fiut, Maria Angélica, Franco, Emília Delesderrier, Rodrigues, Cláudia dos Santos Cople
Tipo de documento: Artigo
Idioma: por
eng
spa
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/3592
Resumo: Introduction: Chemotherapy-induced nausea and vomiting (CINV) are important side effects of antineoplastic treatments. Some medicinal plants have been studied in the management of these effects, such as ginger (Zingiber officinale). Objective: Review the oral use of ginger in the management of CINV in cancer patients. Method: Integrative literature review carried out at the MEDLINE database, in September 2022, utilizing the combination of the keywords “Zingiber officinale” and “Cancer”, filters were also applied to include randomized clinical trials published between 2012 and 2022. Results: In all, nine studies were analyzed. Ginger has the potential to reduce CINV in cancer patients, reflecting positively on quality-of-life, improved appetite and fatigue. The studies have not found any adverse effect after administering ginger. Conclusion: The oral use of ginger proves to be an effective strategy for the management of CINV in cancer patients, in the dosage regimen of 1 g/day of powdered ginger, and can be used as a complementary therapy along with standard antiemetic regimens.
id INCA-1_7f053eee84857f5f6d7fb05810a67e76
oai_identifier_str oai:rbc.inca.gov.br:article/3592
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature ReviewJengibre (Zingiber officinale) en el Tratamiento de las Náuseas y los Vómitos Inducidos por la Quimioterapia en Pacientes con Cáncer: Revisión Integradora de la LiteraturaGengibre (Zingiber officinale) no Manejo de Náuseas e Vômitos Induzidos por Quimioterapia em Pacientes com Câncer: Revisão Integrativa da Literaturaneoplasias/tratamento farmacológicogengibre/efeitos adversosplantas medicinaisfitoterapianeoplasms/drug therapyginger/adverse effectsplants, medicinalphytotherapyneoplasias/tratamiento farmacológicojengibre/efectos adversosplantas medicinalesfitoterapiaIntroduction: Chemotherapy-induced nausea and vomiting (CINV) are important side effects of antineoplastic treatments. Some medicinal plants have been studied in the management of these effects, such as ginger (Zingiber officinale). Objective: Review the oral use of ginger in the management of CINV in cancer patients. Method: Integrative literature review carried out at the MEDLINE database, in September 2022, utilizing the combination of the keywords “Zingiber officinale” and “Cancer”, filters were also applied to include randomized clinical trials published between 2012 and 2022. Results: In all, nine studies were analyzed. Ginger has the potential to reduce CINV in cancer patients, reflecting positively on quality-of-life, improved appetite and fatigue. The studies have not found any adverse effect after administering ginger. Conclusion: The oral use of ginger proves to be an effective strategy for the management of CINV in cancer patients, in the dosage regimen of 1 g/day of powdered ginger, and can be used as a complementary therapy along with standard antiemetic regimens.Introducción: Las náuseas y los vómitos inducidos por la quimioterapia (NVIQ) son efectos secundarios importantes de los tratamientos antineoplásicos. Se han estudiado algunas plantas medicinales en el manejo de estos efectos, como el jengibre (Zingiber officinale). Objetivo: Realizar una revisión integradora de la literatura sobre el uso oral del jengibre en el manejo de las NVIQ en pacientes oncológicos. Método: Revisión integradora de la literatura realizada en la base de datos MEDLINE, en septiembre de 2022, adoptando la combinación de las palabras clave “Zingiber officinale” y “Cancer”. También se aplicaron filtros en la selección para incluir ensayos clínicos aleatorizados publicados entre 2012 y 2022. Resultados: En total, se analizaron nueve estudios. El jengibre tiene el potencial de reducir las NVIQ en pacientes con cáncer, lo que se refleja positivamente en la mejora de la calidad de vida, apetito y fatiga. Los estudios no han observado ningún efecto adverso por la administración del jengibre. Conclusión: El uso del jengibre por vía oral demuestra ser una estrategia segura para el manejo de NVIQ en pacientes con cáncer, usando una dosis de 1 g/día de jengibre en polvo, y puede usarse como terapia complementaria junto con los regímenes antieméticos estándar.Introdução: Náuseas e vômitos induzidos por quimioterapia (NVIQ) são importantes efeitos colaterais dos tratamentos antineoplásicos. Algumas plantas medicinais vêm sendo estudadas no manejo desses efeitos, como o gengibre (Zingiber officinale). Objetivo: Realizar uma revisão acerca do uso via oral do gengibre no manejo de NVIQ em pacientes com câncer. Método: Revisão integrativa da literatura realizada na base de dados MEDLINE, em setembro de 2022, adotando a combinação das palavras-chave “Zingiber officinale” e “Cancer”. Foram também aplicados filtros na seleção para incluir ensaios clínicos aleatórios publicados entre 2012 e 2022. Resultados: Ao todo, foram analisados nove estudos. O gengibre apresenta potencial de reduzir NVIQ em pacientes com câncer, refletindo positivamente na qualidade de vida e na melhora do apetite e da fadiga. Os estudos não observaram efeitos adversos da administração do gengibre. Conclusão: O uso por via oral do gengibre demonstra ser uma estratégia segura para o manejo de NVIQ em pacientes com câncer, na dose de 1 g/dia do gengibre em pó, podendo ser utilizado como terapia complementar juntamente com regimes antieméticos padrões.INCA2023-03-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisão de literaturaapplication/pdfapplication/pdfapplication/pdftext/htmlhttps://rbc.inca.gov.br/index.php/revista/article/view/359210.32635/2176-9745.RBC.2023v69n2.3592Revista Brasileira de Cancerologia; Vol. 69 No. 2 (2023): Apr./May/June; e-033592Revista Brasileira de Cancerologia; Vol. 69 Núm. 2 (2023): abr./mayo/jun.; e-033592Revista Brasileira de Cancerologia; v. 69 n. 2 (2023): abr./maio/jun.; e-0335922176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporengspahttps://rbc.inca.gov.br/index.php/revista/article/view/3592/2735https://rbc.inca.gov.br/index.php/revista/article/view/3592/3261https://rbc.inca.gov.br/index.php/revista/article/view/3592/3015https://rbc.inca.gov.br/index.php/revista/article/view/3592/2746Copyright (c) 2023 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFerreira, Wagner AndradeNeves, Vivian dos SantosFiut, Maria AngélicaFranco, Emília DelesderrierRodrigues, Cláudia dos Santos Cople2023-12-01T18:55:25Zoai:rbc.inca.gov.br:article/3592Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-12-01T18:55:25Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
Jengibre (Zingiber officinale) en el Tratamiento de las Náuseas y los Vómitos Inducidos por la Quimioterapia en Pacientes con Cáncer: Revisión Integradora de la Literatura
Gengibre (Zingiber officinale) no Manejo de Náuseas e Vômitos Induzidos por Quimioterapia em Pacientes com Câncer: Revisão Integrativa da Literatura
title Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
spellingShingle Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
Ferreira, Wagner Andrade
neoplasias/tratamento farmacológico
gengibre/efeitos adversos
plantas medicinais
fitoterapia
neoplasms/drug therapy
ginger/adverse effects
plants, medicinal
phytotherapy
neoplasias/tratamiento farmacológico
jengibre/efectos adversos
plantas medicinales
fitoterapia
title_short Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
title_full Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
title_fullStr Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
title_full_unstemmed Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
title_sort Ginger (Zingiber officinale) in the Management of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: Integrative Literature Review
author Ferreira, Wagner Andrade
author_facet Ferreira, Wagner Andrade
Neves, Vivian dos Santos
Fiut, Maria Angélica
Franco, Emília Delesderrier
Rodrigues, Cláudia dos Santos Cople
author_role author
author2 Neves, Vivian dos Santos
Fiut, Maria Angélica
Franco, Emília Delesderrier
Rodrigues, Cláudia dos Santos Cople
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Ferreira, Wagner Andrade
Neves, Vivian dos Santos
Fiut, Maria Angélica
Franco, Emília Delesderrier
Rodrigues, Cláudia dos Santos Cople
dc.subject.por.fl_str_mv neoplasias/tratamento farmacológico
gengibre/efeitos adversos
plantas medicinais
fitoterapia
neoplasms/drug therapy
ginger/adverse effects
plants, medicinal
phytotherapy
neoplasias/tratamiento farmacológico
jengibre/efectos adversos
plantas medicinales
fitoterapia
topic neoplasias/tratamento farmacológico
gengibre/efeitos adversos
plantas medicinais
fitoterapia
neoplasms/drug therapy
ginger/adverse effects
plants, medicinal
phytotherapy
neoplasias/tratamiento farmacológico
jengibre/efectos adversos
plantas medicinales
fitoterapia
description Introduction: Chemotherapy-induced nausea and vomiting (CINV) are important side effects of antineoplastic treatments. Some medicinal plants have been studied in the management of these effects, such as ginger (Zingiber officinale). Objective: Review the oral use of ginger in the management of CINV in cancer patients. Method: Integrative literature review carried out at the MEDLINE database, in September 2022, utilizing the combination of the keywords “Zingiber officinale” and “Cancer”, filters were also applied to include randomized clinical trials published between 2012 and 2022. Results: In all, nine studies were analyzed. Ginger has the potential to reduce CINV in cancer patients, reflecting positively on quality-of-life, improved appetite and fatigue. The studies have not found any adverse effect after administering ginger. Conclusion: The oral use of ginger proves to be an effective strategy for the management of CINV in cancer patients, in the dosage regimen of 1 g/day of powdered ginger, and can be used as a complementary therapy along with standard antiemetic regimens.
publishDate 2023
dc.date.none.fl_str_mv 2023-03-21
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Revisão de literatura
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3592
10.32635/2176-9745.RBC.2023v69n2.3592
url https://rbc.inca.gov.br/index.php/revista/article/view/3592
identifier_str_mv 10.32635/2176-9745.RBC.2023v69n2.3592
dc.language.iso.fl_str_mv por
eng
spa
language por
eng
spa
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3592/2735
https://rbc.inca.gov.br/index.php/revista/article/view/3592/3261
https://rbc.inca.gov.br/index.php/revista/article/view/3592/3015
https://rbc.inca.gov.br/index.php/revista/article/view/3592/2746
dc.rights.driver.fl_str_mv Copyright (c) 2023 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
text/html
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 69 No. 2 (2023): Apr./May/June; e-033592
Revista Brasileira de Cancerologia; Vol. 69 Núm. 2 (2023): abr./mayo/jun.; e-033592
Revista Brasileira de Cancerologia; v. 69 n. 2 (2023): abr./maio/jun.; e-033592
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042236428386304

Registros relacionados